Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep 1;22(17):5685-8.
doi: 10.1016/j.bmcl.2012.06.098. Epub 2012 Jul 6.

Optimization of tricyclic Nec-3 necroptosis inhibitors for in vitro liver microsomal stability

Affiliations

Optimization of tricyclic Nec-3 necroptosis inhibitors for in vitro liver microsomal stability

Sungwoon Choi et al. Bioorg Med Chem Lett. .

Abstract

Necroptosis is a regulated caspase-independent cell death pathway with morphological features resembling passive non-regulated necrosis. Several diverse structure classes of necroptosis inhibitors have been reported to date, including a series of 3,3a,4,5-tetrahydro-2H-benz[g]indazoles (referred to as the Nec-3 series) displaying potent activity in cellular assays. However, evaluation of the tricyclic necroptosis inhibitor's stability in mouse liver microsomes indicated that they were rapidly degraded. A structure-activity relationship (SAR) study of this compound series revealed that increased liver microsomal stability could be accomplished by modification of the pendent phenyl ring and by introduction of a hydrophilic substituent (i.e., α-hydroxyl) to the acetamide at the 2-position of the tricyclic ring without significantly compromising necroptosis inhibitory activity. Further increases in microsomal stability could be achieved by utilizing the 5,5-dioxo-3-phenyl-2,3,3a,4-tetrahydro-[1]benzothiopyrano[4,3-c]pyrazoles. However, in this case necroptosis inhibitory activity was not maintained. Overall, these results provide a strategy for generating potent and metabolically stable tricyclic necrostatin analogs (e.g., 33, LDN-193191) potentially suitable for in vivo studies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Necrostatins. The numbering convention of 2 is also shown.
Figure 2
Figure 2
Thermal ellipsoidal drawing of 20b as determined by single crystal x-ray analysis.
Scheme 1
Scheme 1
(a) Ar(CH2)nCHO, 8N NaOH, EtOH, rt, 2 h or Ar(CH2)nCHO, conc HCl, MeOH, Δ, 4 h (60 – 75%); (b) R3CO2H, NH2NH2·xH2O, 120 °C, 15 h (70 – 80% when n = 0; 20% when n = 1); (c) H2 (1 atm), 10% Pd/C, EtOH (47–75%); (d) MCPBA, DCM, rt, 16 h (90–96%).
Scheme 2
Scheme 2
(a) NaN(TMS)2, THF, 0 °C, then 4-MeO-PhC(O)Cl, 0 °C to rt (80%); (b) NaN(TMS)2, THF, 0 °C, then MeI, 0 °C to rt (91%); (c) NH2NH2·xH2O, DCM, 4Å molecular sieves (52%); (d) MeC(O)Cl, DCM, −78 °C, then NaBH(OAc)3, −78 °C to rt (95%).

Similar articles

Cited by

References

    1. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison T, Moskowitz M, Yuan J. Nat Chem Biol. 2005;1:112. - PubMed
    1. For review articles related to necroptosis see: Yuan J, Kroemer G. Genes Dev. 2010;24:2592.Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Nat Rev Mol Cell Biol. 2010;11:700.Christofferson DE, Yuan J. Curr Opin Cell Biol. 2010;22:263.Degterev A, Yuan J. Nat Rev Mol Cell Biol. 2008;9:378.

    1. Mehta SL, Manhas N, Raghubir R. Brain Res Rev. 2007;54:34. - PubMed
    2. Lo EH, Dalkara T, Moskowitz MA. Nat Rev Neurosci. 2003;4:399. - PubMed
    1. Whelan RS, Kaplinskiy V, Kitsis RN. Annu Rev Physiol. 2010;72:19. - PubMed
    2. McCully JD, Wakiyama H, Hsieh YJ, Jones M, Levitsky S. Am J Physiol Heart Circ Physiol. 2004;286:H1923. - PubMed
    1. Esposito E, Cuzzocrea S. Curr Med Chem. 2010;17:2764. - PubMed
    2. Martin LJ, Al-Abdulla NA, Brambrink AM, Kirsch JR, Sieber FE, Portera-Cailliau C. Brain Res Bull. 1998;46:281. - PubMed

Publication types